Work

Potent antiviral HIV-1 protease inhibitor combats highly drug resistant mutant PR20

Year: 2019

Type: article

Source: Biochemical and Biophysical Research Communications

DOI: 10.1016/j.bbrc.2019.08.126

Authors: Daniel W. Kneller, Johnson Agniswamy, Arun K. Ghosh, Irene T. Weber

Institutions: Georgia State University, Purdue University West Lafayette

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Energy, Advanced Photon Sciences, Georgia State University, National Institutes of Health, Office of Science, National Institute of Allergy and Infectious Diseases, Basic Energy Sciences, Argonne National Laboratory

Awards: G1756342139, G18202666, G1940553382, Inhibition of Resistant Variants of HIV Protease, Design & Synthesis of Nonpeptide Protease Inhibitors, G9000026535, Design & Synthesis of Nonpeptide Protease Inhibitors

OpenAlex ID: W2970569417

FWCI: 1.916

Cites: 42

Cited by: 14

Related to: 10